Geron Corporation ( GERN ) faced another pipeline setback recently with the company deciding to scrap the development of its phase II oncology candidate, GRN1005. GRN1005, which became a
Continued here:
Geron Scraps GRN1005, Cuts Jobs – Analyst Blog